Crescent Capital BDC (CCAP)
(Delayed Data from NSDQ)
$19.35 USD
+0.60 (3.20%)
Updated Jul 2, 2024 04:00 PM ET
After-Market: $19.34 -0.01 (-0.05%) 7:58 PM ET
1-Strong Buy of 5 1
C Value D Growth D Momentum D VGM
Crescent Capital BDC (CCAP) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$19.20 | $20.00 | $18.00 | 2.40% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for Crescent Capital BDC comes to $19.20. The forecasts range from a low of $18.00 to a high of $20.00. The average price target represents an increase of 2.4% from the last closing price of $18.75.
Analyst Price Targets (5 )
Broker Rating
Crescent Capital BDC currently has an average brokerage recommendation (ABR) of 1.80 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 1.80 a month ago based on five recommendations.
Of the five recommendations deriving the current ABR, two are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 40% and 40% of all recommendations. A month ago, Strong Buy made up 40%, while Buy represented 40%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.80 | 1.80 | 1.80 | 1.80 | 1.80 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
5/23/2024 | Keefe Bruyette & Woods | Paul Johnson | Not Available | Moderate Buy |
5/13/2024 | Wells Fargo Securities | Finian Oshea | Hold | Hold |
5/10/2024 | Raymond James | Robert Dodd | Moderate Buy | Moderate Buy |
2/23/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.80 |
ABR (Last week) | 1.80 |
# of Recs in ABR | 5 |
Average Target Price | $19.20 |
LT Growth Rate | NA |
Industry | Financial - SBIC & Commercial Industry |
Industry Rank by ABR | 155 of 252 |
Current Quarter EPS Est: | 0.58 |